PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Mar-2023 IPS Strengthens Biologics Expertise with New Team Members, Brian Horowski and Bob Forbes Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of G-III Apparel Group, Ltd. (GIII) on Behalf of Investors Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Edgio, Inc. (EGIO) on Behalf of Investors Businesswire
15-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fidelity National Information Services, Inc. (FIS) on Behalf of Investors Businesswire
15-Mar-2023 Vaultree Launches Software Development Kit, Making Scalable Data-In-Use Encryption Generally Available to All Enterprises Businesswire
15-Mar-2023 Edgeworth Economics’ Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog Businesswire
15-Mar-2023 genXtraits Inc. Announces Closing of First Capital Raise Businesswire
15-Mar-2023 Cannabis Industry Webinar: Strategies to Survive and Thrive Businesswire
15-Mar-2023 Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds Businesswire
15-Mar-2023 ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio Businesswire
15-Mar-2023 FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring Businesswire
15-Mar-2023 ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Trial of Novel Disease-Modifying Genetic Medicine, RCT1100 for the Treatment of Primary Ciliary Dyskinesia Businesswire
15-Mar-2023 Sporos BioDiscovery to Present Preclinical Findings on SPR1, a Next-Generation TEAD Inhibitor, at the American Association for Cancer Research (AACR) Annual Meeting 2023 Businesswire
15-Mar-2023 NeuPath Sells Corporate-owned Medical Facility Businesswire
15-Mar-2023 LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business Businesswire
15-Mar-2023 Stoke Therapeutics Announces That FDA Will Allow the Administration of a Higher Single Dose of STK-001 (70mg) in the Ongoing Phase 1/2a MONARCH Study of Children and Adolescents with Dravet Syndrome Businesswire
15-Mar-2023 Silence Therapeutics Reports Fourth Quarter and Full Year 2022 Results Businesswire
15-Mar-2023 Pediatric Medical Devices Market Report 2023: Sector to Reach $51.9 Billion by 2030 at a 7.8% CAGR - ResearchAndMarkets.com Businesswire
15-Mar-2023 Tempo Bioscience Expands Human Liver Models for Toxicity Evaluation and Disease Modeling Businesswire
15-Mar-2023 InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022 Businesswire